COMMUNIQUÉS West-GlobeNewswire

Aardvark Therapeutics Bolsters Leadership Team with Strategic Hires Across Scientific, Commercial, Regulatory and Legal Functions
19/05/2025
Timothy Kieffer, Ph.D., appointed Chief Scientific Officer Danny Villeneuve appointed Chief Commercial Officer Terrie Kellmeyer, Ph.D., appointed Senior Vice President, Regulatory Affairs Christian Zapf, J.D., appointed [...]
Zymeworks Presents Preclinical Data on ZW1528 at the American Thoracic Society International Conference
19/05/2025
Company’s first development candidate in autoimmune and inflammatory disease (AIID) demonstrates potent blockade of IL-4, IL-13, and IL-33 signaling pathways critical in respiratory inflammation Novel bispecific design [...]
CRISPR Therapeutics and Sirius Therapeutics Announce Multi-Target Collaboration to Develop Novel siRNA Therapies
19/05/2025
-Collaboration brings together complementary capabilities to co-develop and co-commercialize SRSD107, a next generation, long-acting Factor XI (FXI) small interfering RNA (siRNA) for the treatment of thromboembolic [...]
Climb Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
19/05/2025
WELLESLEY HILLS, Mass., May 19, 2025 (GLOBE NEWSWIRE) -- Climb Bio, Inc. (Nasdaq: CLYM), a clinical-stage biotechnology company developing therapeutics for patients with immune-mediated diseases, today announced that [...]
Aurora Spine Corporation Schedules Release of First Quarter Fiscal 2025 Financial Results
19/05/2025
CARLSBAD, Calif., May 19, 2025 (GLOBE NEWSWIRE) -- Aurora Spine Corporation (“Aurora Spine” or the “Company”) (TSXV: ASG) (OTCQB: ASAPF), a leader in spine and interventional spine technology that improves spinal [...]
KabaFusion Acquires Infusion Care Assets from Coram® to Expand its Nationwide Footprint of Patient-Focused Services
19/05/2025
Expansion to Increase KabaFusion’s Footprint to 32 Specialty Pharmacies and 19 Ambulatory Infusion Suites Across 26 States LEXINGTON, Mass., May 19, 2025 (GLOBE NEWSWIRE) -- KabaFusion, a nationally recognized leader in [...]
Qualigen Therapeutics, Inc. receives expected notification of deficiency from Nasdaq related to delayed filing of quarterly report on Form 10-Q
19/05/2025
CARLSBAD, Calif., May 19, 2025 (GLOBE NEWSWIRE) -- Qualigen Therapeutics, Inc. (NASDAQ: QLGN) (the “Company”) announced today that it received an expected deficiency notification letter from the Listing Qualifications [...]
Eyenovia Provides Updates on Potential Merger with Betaliq and Development of the Optejet User Filled Device (UFD), and Reports First Quarter 2025 Financial Results
19/05/2025
Eyenovia and Betaliq continue to negotiate a binding merger agreement consistent with the previously announced signed Letter of Intent Reports continued progress on the development of the user-filled Optejet, and [...]
The Coalition to Transform Clinical Trial Engagement Launches National “Champions for Change – PTO Initiative” to Expand Access to Clinical Trials for Working Patients with 7 Corporate and Non-Profit Members
19/05/2025
CHICAGO, May 19, 2025 (GLOBE NEWSWIRE) -- In recognition of Clinical Trials Day, the Coalition to Transform Clinical Trial Engagement (CTCTE) proudly announces the launch of the Champions for Change – Paid Time Off (PTO [...]
Kymera Therapeutics Presents New Preclinical Data for KT-621, a First-In-Class, Oral STAT6 Degrader at the American Thoracic Society International Conference
19/05/2025
KT-621, a potent, selective, oral STAT6 degrader, demonstrated comparable or superior activity to dupilumab in a newly disclosed preclinical chronic asthma model reversing disease progression KT-621 Phase 1 healthy [...]
Global phase III trials demonstrate that nerandomilast slowed lung function decline in IPF and PPF, with similar discontinuation rates to placebo
19/05/2025
Nerandomilast, an investigational agent, met the primary endpoint of both phase III trials, FIBRONEER™-IPF and FIBRONEER™-ILD, significantly reducing the decline in forced vital capacity (FVC) [mL] by absolute change [...]
SPINEWAY : Assemblée Générale Mixte du 4 juin 2025 - Mise à disposition des documents préparatoires
19/05/2025
Communiqué de presse Ecully, le 19 mai 2025 – 18h30 SPINEWAY Assemblée Générale Mixte du 4 juin 2025 Mise à disposition des documents préparatoires Spineway informe ses actionnaires qu’ils sont invités à participer à l’ [...]
Spineway : Combined General Meeting of June 4, 2025 - Availability of preparatory documents
19/05/2025
Press release Ecully, May 19, 2025 – 6.30 p.m. SPINEWAY Combined General Meeting of June 4, 2025 Availability of preparatory documents Spineway informs its shareholders that they are invited to attend the Combined [...]
Early and Sustained Increase in Serum TTR Levels by Acoramidis Independently Predicted Improved Survival in the ATTRibute-CM Study
19/05/2025
- For each 5-mg/dL increase in serum TTR level within 28 days of starting treatment, the relative risk reduction of mortality was up to 31.6% through Month 30, confirming the hypothesis that ever better levels of [...]
IBA – ACQUISITION D’ACTIONS PROPRES
19/05/2025
Publication immédiate – 19 mai 2025 Louvain-la-Neuve, Belgique, 19 mai 2025 - Conformément à l'article 8:4 de l'arrêté royal du 29 avril 2019 portant exécution du Code belge des sociétés et associations, Ion Beam [...]
IBA – ACQUISITION OF OWN SHARES
19/05/2025
Immediate Release – May 19 th , 2025 Louvain-la-Neuve, Belgium, May 19 th , 2025 - In accordance with article 8:4 of the Royal Decree of 29 April 2019 executing the Belgian Code on Companies and Associations, Ion Beam [...]
Eurobio Scientific : EB Development franchit à la hausse le seuil de 90%
19/05/2025
EB Development franchit à la hausse le seuil de 90% Paris, le 19 mai 2024 - 17h40 - Eurobio Scientific (FR0013240934, ALERS, éligible PEA-PME), groupe français leader dans le diagnostic médical in vitro et les sciences [...]
Eurobio Scientific: EB Development rises above 90% threshold
19/05/2025
EB Development rises above 90% threshold Paris, May 19, 2024 – 7:00 pm - Eurobio Scientific (FR0013240934, ALERS, PEA-PME eligible), a leading French group in in vitro medical diagnostics and life sciences, was informed [...]
Hospice Choices: VITAS® Healthcare Is Now Serving Marion County, Florida
19/05/2025
Florida’s most trusted hospice provider now reaches 59 of the state’s 67 counties OCALA, Fla., May 19, 2025 (GLOBE NEWSWIRE) -- Residents of North Central Florida now have easier access to high-quality, compassionate [...]

Pages